This section provides information about Imunovir® specific to the United Kingdom and the Republic of Ireland and is not intended to replace the advice of a healthcare professional. Imunovir® is a Prescription Only Medicine.
Please consult your healthcare professional for further advice and information on your condition and medication.
UK
Imunovir tablets are indicated in the management of:
(a) Mucocutaneous infections due to herpes simplex virus (type 1 and/or type II).
(b) Genital warts as adjunctive therapy to podophyllin or carbon dioxide laser.
(c) Subacute sclerosing panencephalitis (SSPE).
Presentation: Blister Pack
Marketing Authorisation Number:
UK: PL 39972/0001
Click here for product SmPC
Click here for patient leaflet PIL
Marketing Authorisation Holder:
Kora Corporation Limited (trading as Kora Healthcare)
20 Harcourt Street
Dublin
D02 H364
Ireland
Ireland
Imunovir tablets are indicated:
(a) As an immunomodulator for the management of patients with immunodepression suffering from viral infections such as subacute sclerosing panencephalitis, varicella, herpes simplex Type 1 & 2.
(b) As an adjunct to podophyllin or carbon dioxide laser in treatment of patients with genital warts
Presentation: Blister Pack
Marketing Authorisation Number:
Ireland: PA 1748/001/001
Click here for product SmPC
Click here for patient leaflet PIL
Marketing Authorisation Holder:
Kora Corporation Limited (trading as Kora Healthcare)
20 Harcourt Street
Dublin
D02 H364
Ireland
Date of Preparation: May 2025
#164174
